New guidelines for stroke prevention from the American Stroke Association emphasize the benefits of GLP-1 drugs, a balanced ...

Every medication, regardless of its intended use, comes with some risks. Unfortunately, they aren't always apparent right away. In some cases, doctors only learn about the risks of some medications ...

As the EU patent expires on its flagship respiratory diseases product, Spiriva, Boehringer Ingelheim is looking to newer diabetes and respiratory drugs under the leadership of a new CEO.

Both the CDC and the FDA warn against treating this common childhood condition on your own with non-prescription treatments. See what they recommend.